How effective is nicotine replacement therapy in helping people to stop smoking?

J L Tang1, M Law, N Wald

  • 1Department of Environmental and Preventive Medicine, Wolfson Institute of Preventive Medicine, St Bartholomew's Hospital Medical College, London.

BMJ (Clinical Research Ed.)
|January 1, 1994
PubMed
Abstract

Insights

Nicotine replacement therapy, including gum and patches, effectively helps dependent smokers quit. The 4 mg gum is most effective for highly dependent smokers, potentially aiding one-third to quit.

Area of Science:

  • Public Health
  • Addiction Medicine
  • Pharmacology

Background:

  • Smoking remains a leading cause of preventable death worldwide.
  • Nicotine dependence is a complex addiction requiring effective cessation strategies.
  • Nicotine replacement therapy (NRT) is a widely used intervention to aid smoking cessation.

Purpose of the Study:

  • To evaluate the effectiveness of NRT in helping individuals stop smoking.
  • To compare the efficacy of different NRT formulations (gum and patch).

Main Methods:

  • Systematic analysis of 28 randomized trials of 2 mg nicotine gum, 6 trials of 4 mg nicotine gum, and 6 trials of nicotine transdermal patches.
  • Efficacy measured by the difference in smoking cessation rates at one year between NRT users and controls.
  • Subject recruitment included self-referred individuals and those invited from general practices or hospitals.

Main Results:

  • Both nicotine gum and patches demonstrated significant efficacy (P < 0.001) in smoking cessation.
  • Nicotine 2 mg gum showed 6% overall efficacy, higher in self-referred (11%) versus invited (3%) subjects.
  • Efficacy was strongly linked to nicotine dependence; 16% cessation in highly dependent smokers, with no significant effect in low dependence smokers.
  • The 4 mg gum was effective in approximately one-third of highly dependent smokers.
  • Nicotine patch efficacy (9% overall) showed less dependence on nicotine levels, possibly due to its delivery method.

Conclusions:

  • NRT (gum and patch) are effective tools for nicotine-dependent smokers seeking to quit.
  • For highly dependent smokers, 4 mg nicotine gum is the most effective NRT, potentially enabling one-third to stop.
  • For less dependent smokers, different NRT preparations are comparable, with patches offering convenience.
  • Overall, NRT can assist approximately 15% of smokers who seek help to quit smoking.

Related Concept Videos

Drug Dependence01:17

Drug Dependence

Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants


Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Stimulants01:29

Stimulants

Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...